Concepedia
Statistics
Publications
9
Citations
238
H-Index
Active since
2009
Affiliations
Janssen (Belgium)(Current)
Janssen (United States)
Vertex Pharmaceuticals (United States)
Janssen (Netherlands)
Texas Liver Institute
Ann Vandevoorde is an author at Janssen (Belgium) specializing in antiviral therapy, pharmacy, and clinical pharmacology.
Publications per year
2009–2016
Effects of ritonavir‐boosted darunavir <i>vs</i>. ritonavir‐boosted atazanavir on lipid and glucose parameters in HIV‐negative, healthy volunteers
F Tomaka, Éric Lefebvre, V. Sekar et al. · HIV Medicine · 2009 · 44 citations
Pharmacy, Pharmacology, Pharmacotherapy +17
Week 96 Efficacy, Virology and Safety of Darunavir/r Versus Lopinavir/r in Treatment-Experienced Patients in TITAN
Dénes Bánhegyi, Christine Katlama, Clóvis Arns da Cunha et al. · Current HIV Research · 2012 · 41 citations
Simeprevir, daclatasvir and sofosbuvir for hepatitis C virus‐infected patients with decompensated liver disease
Eric Lawitz, Fred Poordad, Julio Gutiérrez et al. · Journal of Viral Hepatitis · 2016 · 31 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacotherapy +17
1244 THE PHARMACOKINETIC INTERACTION BETWEEN METHADONE AND THE INVESTIGATIONAL HCV PROTEASE INHIBITOR TELAPREVIR
Rolf van Heeswijk, Ann Vandevoorde, Pieter Verboven et al. · Journal of Hepatology · 2011 · 29 citations
Pharmacy, Pharmacokinetics, Pharmacology +10
Pharmacokinetic Interaction between Telaprevir and Methadone
Rolf van Heeswijk, Pieter Verboven, Ann Vandevoorde et al. · Antimicrobial Agents and Chemotherapy · 2013 · 28 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +14
1–5 of 9